333 related articles for article (PubMed ID: 8669489)
1. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
[TBL] [Abstract][Full Text] [Related]
4. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization.
Lloyd RV; Jin L; Fields K; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
[TBL] [Abstract][Full Text] [Related]
6. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas.
Jin L; Kulig E; Qian X; Scheithauer BW; Young WF; Davis DH; Seidah NG; Chretien M; Lloyd RV
Pituitary; 1999 May; 1(3-4):187-95. PubMed ID: 11081197
[TBL] [Abstract][Full Text] [Related]
7. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
8. Pancreastatin, a chromogranin A-derived peptide, inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture.
Zhang JX; Fasciotto BH; Darling DS; Cohn DV
Endocrinology; 1994 Mar; 134(3):1310-6. PubMed ID: 8119171
[TBL] [Abstract][Full Text] [Related]
9. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chromogranin/secretogranin messenger RNAs in human pituitary adenomas.
Lloyd RV; Jin L
Diagn Mol Pathol; 1994 Mar; 3(1):38-45. PubMed ID: 8162254
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.
Pawlikowski M; Gruszka A; Radek M; Kunert-Radek J
Folia Histochem Cytobiol; 2004; 42(4):245-7. PubMed ID: 15704652
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
Heaney AP; Curry WJ; Pogue KM; Armstrong VL; Mirakhur M; Sheridan B; Johnston CF; Buchanan KD; Atkinson AB
Pituitary; 2000 Oct; 3(2):67-75. PubMed ID: 11141698
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.
Jin L; Zhang S; Bayliss J; Scheithauer B; Qian X; Kobayashi I; Stridsberg M; Lloyd RV
Endocr Pathol; 2003; 14(1):37-48. PubMed ID: 12746561
[TBL] [Abstract][Full Text] [Related]
15. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
17. In situ hybridization histochemistry of mRNAs for hormones and chromogranins in normal pituitary tissue and pituitary adenoma.
Kilár F; Muhr C; Funa K
Acta Endocrinol (Copenh); 1991 Dec; 125(6):628-36. PubMed ID: 1789058
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A does not mediate glucocorticoid inhibition of adrenocorticotropin secretion.
Horiba N; Nicholson WE; Ch'ng JL; Orth DN
Endocrinology; 1993 Apr; 132(4):1585-92. PubMed ID: 8384991
[TBL] [Abstract][Full Text] [Related]
19. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
[TBL] [Abstract][Full Text] [Related]
20. Study of the involvement of pancreastatin in the physiopathology of diabetes mellitus associated with nonsecreting pituitary adenomas.
Prévost G; Eas F; Duparc C; Cauliez B; Laquérrière A; Fréger P; Lefebvre H; Kuhn JM
Horm Metab Res; 2012 Oct; 44(11):861-5. PubMed ID: 22864906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]